Your browser doesn't support javascript.
loading
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
Venook, Alan P; Niedzwiecki, Donna; Lenz, Heinz-Josef; Innocenti, Federico; Fruth, Briant; Meyerhardt, Jeffrey A; Schrag, Deborah; Greene, Claire; O'Neil, Bert H; Atkins, James Norman; Berry, Scott; Polite, Blase N; O'Reilly, Eileen M; Goldberg, Richard M; Hochster, Howard S; Schilsky, Richard L; Bertagnolli, Monica M; El-Khoueiry, Anthony B; Watson, Peter; Benson, Al B; Mulkerin, Daniel L; Mayer, Robert J; Blanke, Charles.
Afiliação
  • Venook AP; University of California, San Francisco.
  • Niedzwiecki D; Department of Biostatistics and Bioinformatics and Alliance Statistics and Data Center, Duke University Medical Center, Durham, North Carolina.
  • Lenz HJ; University of Southern California, Los Angeles.
  • Innocenti F; University of North Carolina at Chapel Hill.
  • Fruth B; Alliance Statistics and Data Center, Mayo Clinic Cancer Center, Rochester, Minnesota.
  • Meyerhardt JA; Dana-Farber/Partners CancerCare, Boston, Massachusetts.
  • Schrag D; Dana-Farber/Partners CancerCare, Boston, Massachusetts.
  • Greene C; University of California, San Francisco.
  • O'Neil BH; Indiana University, Simon Cancer Center, Indianapolis.
  • Atkins JN; National Surgical Adjuvant Breast and Bowel Project/NRG Oncology, and Southeastern Medical Oncology Center, Goldsboro, North Carolina.
  • Berry S; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Canada.
  • Polite BN; University of Chicago Comprehensive Cancer Center, Chicago, Illinois.
  • O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Goldberg RM; Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital, Columbus.
  • Hochster HS; Department of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut.
  • Schilsky RL; American Society of Clinical Oncology, Alexandria, Virginia.
  • Bertagnolli MM; Brigham and Women's Hospital, Boston, Massachusetts.
  • El-Khoueiry AB; University of Southern California, Los Angeles.
  • Watson P; Lenoir Memorial Hospital/Kinston Medical Specialists PA, Kinston, North Carolina.
  • Benson AB; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois.
  • Mulkerin DL; University of Wisconsin, Madison.
  • Mayer RJ; Dana-Farber/Partners CancerCare, Boston, Massachusetts.
  • Blanke C; Southwest Oncology Group Chair's Office and Knight Cancer Institute, Oregon Health & Science University, Portland.
JAMA ; 317(23): 2392-2401, 2017 06 20.
Article em En | MEDLINE | ID: mdl-28632865
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores da Angiogênese / Bevacizumab / Cetuximab / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged80 País/Região como assunto: America do norte Idioma: En Revista: JAMA Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores da Angiogênese / Bevacizumab / Cetuximab / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged80 País/Região como assunto: America do norte Idioma: En Revista: JAMA Ano de publicação: 2017 Tipo de documento: Article